共 50 条
- [33] How can we improve the assessment of safety in child and adolescent psychopharmacology? [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 634 - 641
- [34] Challenges and Promises of Pediatric Psychopharmacology [J]. ACADEMIC PEDIATRICS, 2016, 16 (06) : 508 - 518
- [36] New Horizons in Pediatric Psychopharmacology [J]. DRUG DEVELOPMENT RESEARCH, 2016, 77 (08) : 474 - 478
- [37] Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (12): : 1488 - 1496
- [38] Pediatric psychopharmacology: Principles and practice [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06): : 1141 - 1142
- [39] Regulatory issues in pediatric psychopharmacology [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (10): : 1276 - 1282
- [40] Pediatric Psychopharmacology for Primary Care [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (08): : 622 - 623